1
|
Wang R, Gu A, Li F, Ma Q, Yin Q, Nie K, Fu S, Cui Q, Xu S, Li H, Wang H. Evolutionary Patterns and Genotype-Specific Amino Acid Mutations of Tick-Borne Encephalitis Virus. Int J Mol Sci 2025; 26:954. [PMID: 39940723 PMCID: PMC11817229 DOI: 10.3390/ijms26030954] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/27/2024] [Revised: 01/20/2025] [Accepted: 01/21/2025] [Indexed: 02/16/2025] Open
Abstract
Tick-borne encephalitis virus (TBEV) is a significant tick-borne flavivirus responsible for severe human diseases. Here, we analyzed the genetic diversity and evolutionary dynamics of TBEV using 263 genome sequences from the NCBI database and identified key amino acid mutations. TBEV sequences were classified into five genotypes-Baikalian, European, Far-Eastern, Himalaya, and Siberian-showing ORF nucleotide similarity of 81.5% to 88.0% and amino acid similarity of 93.0% to 96.4%. Extensive recombination between genotypes was not observed. Entropy analyses revealed highly variable sites distributed across the Baikalian (n = 2), European (n = 3), Far-Eastern (n = 5), and Siberian (n = 13) genotypes. Each genotype exhibited specific amino acid mutations. Positive selection analysis identified sites under selection in the full dataset (n = 2), as well as in the European (n = 6), Far-Eastern (n = 7), and Siberian (n = 4) genotypes. By integrating highly variable sites, shared genotype-specific mutations, and positively selected sites, we identified 37 key amino acid positions, primarily located on the surfaces of viral proteins. These positions may have a potential impact on protein function and pathogenicity, though further studies are required to validate and evaluate these effects comprehensively. This study provides the first comprehensive analysis of mutational landscapes across TBEV genotypes, uncovering potential critical mutations that may shape viral biology and pathogenicity, and offers valuable insights for further exploration of TBEV characteristics.
Collapse
Affiliation(s)
- Ruichen Wang
- National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China; (R.W.); (A.G.); (F.L.); (Q.Y.); (K.N.); (S.F.); (Q.C.); (S.X.)
| | - Anqi Gu
- National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China; (R.W.); (A.G.); (F.L.); (Q.Y.); (K.N.); (S.F.); (Q.C.); (S.X.)
- Chinese Center for Disease Control and Prevention, Beijing 102206, China;
| | - Fan Li
- National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China; (R.W.); (A.G.); (F.L.); (Q.Y.); (K.N.); (S.F.); (Q.C.); (S.X.)
| | - Qian Ma
- Chinese Center for Disease Control and Prevention, Beijing 102206, China;
| | - Qikai Yin
- National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China; (R.W.); (A.G.); (F.L.); (Q.Y.); (K.N.); (S.F.); (Q.C.); (S.X.)
| | - Kai Nie
- National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China; (R.W.); (A.G.); (F.L.); (Q.Y.); (K.N.); (S.F.); (Q.C.); (S.X.)
| | - Shihong Fu
- National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China; (R.W.); (A.G.); (F.L.); (Q.Y.); (K.N.); (S.F.); (Q.C.); (S.X.)
| | - Qianqian Cui
- National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China; (R.W.); (A.G.); (F.L.); (Q.Y.); (K.N.); (S.F.); (Q.C.); (S.X.)
| | - Songtao Xu
- National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China; (R.W.); (A.G.); (F.L.); (Q.Y.); (K.N.); (S.F.); (Q.C.); (S.X.)
| | - Hao Li
- Chinese Center for Disease Control and Prevention, Beijing 102206, China;
| | - Huanyu Wang
- National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China; (R.W.); (A.G.); (F.L.); (Q.Y.); (K.N.); (S.F.); (Q.C.); (S.X.)
| |
Collapse
|
2
|
Halsby K, Dobler G, Easton A, Karelis G, Krbková L, Kyncl J, Sellner J, Strle F, Veje M, Zajkowska J, Zavadska D, Angulo FJ, Pilz A, Erber W, Gabriel M, Russo J, Price M, Madhava H, Meyding-Lamadé UK. Evaluating the need for standardised disease manifestation categories in patients infected with the tick-borne encephalitis virus: A Delphi panel. Ticks Tick Borne Dis 2025; 16:102431. [PMID: 39708718 DOI: 10.1016/j.ttbdis.2024.102431] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/08/2024] [Revised: 11/07/2024] [Accepted: 12/15/2024] [Indexed: 12/23/2024]
Abstract
Categorization systems for tick-borne encephalitis virus (TBEV) infection lack consistency in classifying disease severity. To evaluate the need for a standard, consensus-based categorisation system for TBEV infection across subtypes, we gathered an expert panel of clinicians and scientists with diverse expertise in TBEV infection. Consensus was sought using the Delphi technique, which consisted of 2 web-based survey questionnaires and a final, virtual, consensus-building exercise. Ten panellists representing 8 European countries participated in the Delphi exercise, with specialities in neurology, infectious disease, paediatrics, immunology, virology, and epidemiology. Panellists reached unanimous consensus on the need for a standardised, international categorisation system to capture both clinical presentation and severity of TBEV infection. Ideally, such a system should be feasible for use at bedside, be clear and easy to understand, and capture both the acute and follow-up phases of TBEV infection. Areas requiring further discussion were (1) the timepoints at which assessments should be made and (2) whether there should be a separate system for children. This Delphi panel study found that a critical gap persists in the absence of a feasible and practical classification system for TBEV infection. Specifically, the findings of our Delphi exercise highlight the need for the development of a user-friendly classification system that captures the acute and follow-up (i.e., outcome) phases of TBEV infection and optimally reflects both clinical presentation and severity. Development of a clinical categorisation system will enhance patient care and foster comparability among studies, thereby supporting treatment development, refining vaccine strategies, and fortifying public health surveillance.
Collapse
Affiliation(s)
- Kate Halsby
- Vaccines and Antivirals Medical Affairs, Pfizer Ltd, Surrey, United Kingdom.
| | - Gerhard Dobler
- Bundeswehr Institute of Microbiology, Munich, Germany; Department of Infectious Diseases and Tropical Medicine, University Munich, Germany
| | - Ava Easton
- Encephalitis International, North Yorkshire, United Kingdom; Institute of Infection, Veterinary and Ecological Science, University of Liverpool, NIHR HPRU for Emerging and Zoonotic Infection, Liverpool, United Kingdom
| | - Guntis Karelis
- Rīga Stradiņš University, Dzirciema St. 16, Rīga, LV-1007, Latvia; Rīga East University Hospital, Hipokrata St. 2, Rīga, LV-1079, Latvia
| | - Lenka Krbková
- Department of Pediatric Infectious Diseases, Faculty of Medicine, Masaryk University and Faculty Hospital, Brno, Czech Republic
| | - Jan Kyncl
- Department of Infectious Diseases Epidemiology, National Institute of Public Health, Srobarova 49, Prague, Czech Republic; Department of Epidemiology and Biostatistics, Third Faculty of Medicine, Charles University, Ruska 87, Prague, Czech Republic
| | - Johann Sellner
- Department of Neurology, Landesklinikum Mistelbach-Gänserndorf, Mistelbach, Affiliated with Karl Landsteiner University of Health Sciences, Krems, Austria
| | - Franc Strle
- Department of Infectious Diseases, University Medical Centre Ljubljana, Japljeva 2, 1525 Ljubljana, Slovenia
| | - Malin Veje
- Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy at Gothenburg University, Guldhedsgatan 10, 41346, Gothenburg, Sweden
| | - Joanna Zajkowska
- Department of Infectious Diseases and Neuroinfections, Medical University of Bialystok, Żurawia 14, Białystok 15-540, Poland
| | - Dace Zavadska
- Riga Stradins University, Department of Paediatrics, Children Clinical University Hospital, Riga, Vienibas gatve 45, Riga, LV1004, Latvia
| | - Frederick J Angulo
- Vaccines and Antivirals Medical Affairs, Pfizer Biopharma Group, 500 Arcola Rd, Collegeville, PA,19426, United States
| | - Andreas Pilz
- Vaccines and Antivirals Medical Affairs, Pfizer Corporation Austria, Vienna, Austria
| | - Wilhelm Erber
- Vaccines and Antivirals Medical Affairs, Pfizer Corporation Austria, Vienna, Austria
| | - Meghan Gabriel
- RTI Health Solutions, 3040 East Cornwallis Road, Research Triangle Park, NC, United States
| | - Jon Russo
- RTI Health Solutions, 3040 East Cornwallis Road, Research Triangle Park, NC, United States
| | - Mark Price
- RTI Health Solutions, 3040 East Cornwallis Road, Research Triangle Park, NC, United States
| | - Harish Madhava
- Vaccines and Antivirals Medical Affairs, Pfizer Ltd, Surrey, United Kingdom
| | | |
Collapse
|
3
|
Boldbaatar B, Cleary NG, Paoli JE, Lee DW, Altantogtokh D, Matulis GA, Cote N, Fiorenzano J, Etobayeva IV, Kwon JH, Mavian C, Letizia AG, von Fricken ME. Characterization of Tick-Borne Encephalitis Virus Isolates from Ixodes persulcatus Ticks Collected During 2020 in Selenge, Mongolia. Pathogens 2024; 13:1086. [PMID: 39770346 PMCID: PMC11677234 DOI: 10.3390/pathogens13121086] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/18/2024] [Revised: 12/02/2024] [Accepted: 12/07/2024] [Indexed: 01/11/2025] Open
Abstract
Tick-borne encephalitis virus (TBEV) causes neurological disease in humans, with varied clinical severity influenced by the viral subtype. TBEV is endemic to Mongolia, where both Siberian and Far-Eastern subtypes are present. Ixodes persulcatus is considered the main vector of TBEV in Mongolia; although, the virus has also been detected in Dermacentor species. To further characterize the disease ecology of TBEV within the endemic Selenge province of Mongolia, 1300 Ixodes persulcatus ticks were collected in May 2020 from regions outside Ulaanbaatar. Pooled tick samples (n = 20-50) were homogenized and the supernatant was inoculated into Vero cells. Two RT-PCR assays were conducted on the cell supernatant following an observed cytopathic effect: one for TBEV detection and the second for viral subtyping. Lysed cell cultures were processed for next-generation sequencing (NGS) using Illumina technology. TBEV was detected in 10.7% of tick pools (3/28), and isolates were identified as the Siberian subtype. Phylogenetic analysis showed PQ479142 clustering within the Siberian subtype and sharing high similarity with published isolates collected in Selenge in 2012 from Ixodes persulcatus. Subtype analysis of circulating TBEV isolates and sequencing analytics to track viral evolution in ticks are vital to continued understanding of the risk to local populations.
Collapse
Affiliation(s)
- Bazartseren Boldbaatar
- School of Veterinary Medicine, Mongolian University of Life Sciences, Ulaanbaatar 17029, Mongolia;
| | - Nora G. Cleary
- Department of Environmental and Global Health, University of Florida, Gainesville, FL 32610, USA; (N.G.C.); (G.A.M.)
- Emerging Pathogens Institute, University of Florida, Gainesville, FL 32610, USA; (J.E.P.); (C.M.)
| | - Julia E. Paoli
- Emerging Pathogens Institute, University of Florida, Gainesville, FL 32610, USA; (J.E.P.); (C.M.)
- Department of Pathology, Immunology and Laboratory Medicine, University of Florida, Gainesville, FL 32610, USA
| | - Dong-Wook Lee
- College of Veterinary Medicine, Kyungpook National University, Daegu 41566, Republic of Korea; (D.-W.L.); (J.-H.K.)
| | | | - Graham A. Matulis
- Department of Environmental and Global Health, University of Florida, Gainesville, FL 32610, USA; (N.G.C.); (G.A.M.)
- Emerging Pathogens Institute, University of Florida, Gainesville, FL 32610, USA; (J.E.P.); (C.M.)
| | - Noel Cote
- Naval Medical Research Unit INDO PACIFIC (NAMRU-IP), Singapore 759657, Singapore; (N.C.); (J.F.); (I.V.E.); (A.G.L.)
| | - Jodi Fiorenzano
- Naval Medical Research Unit INDO PACIFIC (NAMRU-IP), Singapore 759657, Singapore; (N.C.); (J.F.); (I.V.E.); (A.G.L.)
- Armed Forces Pest Management Board, Silver Spring, MD 20910, USA
| | - Irina V. Etobayeva
- Naval Medical Research Unit INDO PACIFIC (NAMRU-IP), Singapore 759657, Singapore; (N.C.); (J.F.); (I.V.E.); (A.G.L.)
| | - Jung-Hoon Kwon
- College of Veterinary Medicine, Kyungpook National University, Daegu 41566, Republic of Korea; (D.-W.L.); (J.-H.K.)
| | - Carla Mavian
- Emerging Pathogens Institute, University of Florida, Gainesville, FL 32610, USA; (J.E.P.); (C.M.)
- Department of Pathology, Immunology and Laboratory Medicine, University of Florida, Gainesville, FL 32610, USA
- Smithsonian Institution, Washington, DC 20024, USA
| | - Andrew G. Letizia
- Naval Medical Research Unit INDO PACIFIC (NAMRU-IP), Singapore 759657, Singapore; (N.C.); (J.F.); (I.V.E.); (A.G.L.)
| | - Michael E. von Fricken
- Department of Environmental and Global Health, University of Florida, Gainesville, FL 32610, USA; (N.G.C.); (G.A.M.)
- Emerging Pathogens Institute, University of Florida, Gainesville, FL 32610, USA; (J.E.P.); (C.M.)
- Smithsonian Institution, Washington, DC 20024, USA
| |
Collapse
|
4
|
Kauer L, Dobler G, Schmuck HM, Chitimia‐Dobler L, Pfeffer M, Kühn R. Interrelation of the spatial and genetic structure of tick-borne encephalitis virus, its reservoir host ( Myodes glareolus), and its vector ( Ixodes ricinus) in a natural focus area. Ecol Evol 2024; 14:e70163. [PMID: 39165543 PMCID: PMC11333545 DOI: 10.1002/ece3.70163] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/17/2023] [Revised: 06/21/2024] [Accepted: 07/26/2024] [Indexed: 08/22/2024] Open
Abstract
Tick-borne encephalitis (TBE) virus is considered the medically most important arthropod-borne virus in Europe. Although TBE is endemic throughout central Europe, ticks and rodents determine its maintenance in small, difficult-to-assess, natural foci. We investigated the interrelation between the population genetics of the main TBE virus (TBEV) vector tick (Ixodes ricinus), the most important reservoir host (Myodes glareolus, syn. Clethrionomys glareolus), and TBEV. Rodents and ticks were sampled on 15 sites within an exploratory study area, which has been screened regularly for TBEV occurrence in ticks for more than 10 years. On all 15 sites, ticks and bank voles were sampled, screened for TBEV presence via serology and RT-PCR, and genetically examined. Moreover, TBEV isolates derived from these analyses were sequenced. In long-term TBEV foci bank vole populations show extraordinary genetic constitutions, leading to a particular population structure, whereas ticks revealed a panmictic genetic structure overall sampling sites. Landscape genetics and habitat connectivity modeling (analysis of isolation by resistance) showed no landscape-related barriers explaining the genetic structure of the bank vole populations. The results suggest that bank voles do not simply serve as TBEV reservoirs, but their genetic composition appears to have a significant influence on establishing and maintaining long-term natural TBEV foci, whereas the genetic structure of TBEV's main vector I. ricinus does not play an important role in the sustainability of long-term TBEV foci. A thorough investigation of how and to which extent TBEV and M. glareolus genetics are associated is needed to further unravel the underlying mechanisms.
Collapse
Affiliation(s)
- Lea Kauer
- Molecular Zoology, Department of Zoology, TUM School of Life SciencesTechnical University of MunichFreisingGermany
| | | | - Hannah M. Schmuck
- Institute of Animal Hygiene and Veterinary Public HealthUniversity of LeipzigLeipzigGermany
| | | | - Martin Pfeffer
- Institute of Animal Hygiene and Veterinary Public HealthUniversity of LeipzigLeipzigGermany
| | - Ralph Kühn
- Molecular Zoology, Department of Zoology, TUM School of Life SciencesTechnical University of MunichFreisingGermany
- Department of Fish, Wildlife and Conservation EcologyNew Mexico State UniversityLas CrucesNew MexicoUSA
| |
Collapse
|
5
|
Wang R, Liu S, Sun H, Xu C, Wen Y, Wu X, Zhang W, Nie K, Li F, Fu S, Yin Q, He Y, Xu S, Liang G, Deng L, Wei Q, Wang H. Metatranscriptomics Reveals the RNA Virome of Ixodes Persulcatus in the China-North Korea Border, 2017. Viruses 2023; 16:62. [PMID: 38257762 PMCID: PMC10819109 DOI: 10.3390/v16010062] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/27/2023] [Revised: 12/19/2023] [Accepted: 12/27/2023] [Indexed: 01/24/2024] Open
Abstract
In recent years, numerous viruses have been identified from ticks, and some have been linked to clinical cases of emerging tick-borne diseases. Chinese northeast frontier is tick infested. However, there is a notable lack of systematic monitoring efforts to assess the viral composition in the area, leaving the ecological landscape of viruses carried by ticks not clear enough. Between April and June 2017, 7101 ticks were collected to perform virus surveillance on the China-North Korea border, specifically in Tonghua, Baishan, and Yanbian. A total of 2127 Ixodes persulcatus were identified. Further investigation revealed the diversity of tick-borne viruses by transcriptome sequencing of Ixodes persulcatus. All ticks tested negative for tick-borne encephalitis virus. Transcriptome sequencing expanded 121 genomic sequence data of 12 different virus species from Ixodes persulcatus. Notably, a new segmented flavivirus, named Baishan Forest Tick Virus, were identified, closely related to Alongshan virus and Harz mountain virus. Therefore, this new virus may pose a potential threat to humans. Furthermore, the study revealed the existence of seven emerging tick-borne viruses dating back to 2017. These previously identified viruses included Mudanjiang phlebovirus, Onega tick phlebovirus, Sara tick phlebovirus, Yichun mivirus, and three unnamed viruses (one belonging to the Peribunyaviridae family and the other two belonging to the Phenuiviridae family). The existence of these emerging tick-borne viruses in tick samples collected in 2017 suggests that their history may extend further than previously recognized. This study provides invaluable insights into the virome of Ixodes persulcatus in the China-North Korea border region, enhancing our ongoing efforts to manage the risks associated with tick-borne viruses.
Collapse
Affiliation(s)
- Ruichen Wang
- National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China; (R.W.); (S.L.); (C.X.); (Y.W.); (W.Z.); (K.N.); (F.L.); (S.F.); (Q.Y.); (Y.H.); (S.X.); (G.L.)
| | - Shenghui Liu
- National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China; (R.W.); (S.L.); (C.X.); (Y.W.); (W.Z.); (K.N.); (F.L.); (S.F.); (Q.Y.); (Y.H.); (S.X.); (G.L.)
| | - Hongliang Sun
- Changchun Institute of Biological Products Co., Ltd., Changchun 130012, China; (H.S.); (X.W.)
| | - Chongxiao Xu
- National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China; (R.W.); (S.L.); (C.X.); (Y.W.); (W.Z.); (K.N.); (F.L.); (S.F.); (Q.Y.); (Y.H.); (S.X.); (G.L.)
| | - Yanhan Wen
- National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China; (R.W.); (S.L.); (C.X.); (Y.W.); (W.Z.); (K.N.); (F.L.); (S.F.); (Q.Y.); (Y.H.); (S.X.); (G.L.)
| | - Xiwen Wu
- Changchun Institute of Biological Products Co., Ltd., Changchun 130012, China; (H.S.); (X.W.)
| | - Weijia Zhang
- National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China; (R.W.); (S.L.); (C.X.); (Y.W.); (W.Z.); (K.N.); (F.L.); (S.F.); (Q.Y.); (Y.H.); (S.X.); (G.L.)
| | - Kai Nie
- National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China; (R.W.); (S.L.); (C.X.); (Y.W.); (W.Z.); (K.N.); (F.L.); (S.F.); (Q.Y.); (Y.H.); (S.X.); (G.L.)
| | - Fan Li
- National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China; (R.W.); (S.L.); (C.X.); (Y.W.); (W.Z.); (K.N.); (F.L.); (S.F.); (Q.Y.); (Y.H.); (S.X.); (G.L.)
| | - Shihong Fu
- National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China; (R.W.); (S.L.); (C.X.); (Y.W.); (W.Z.); (K.N.); (F.L.); (S.F.); (Q.Y.); (Y.H.); (S.X.); (G.L.)
| | - Qikai Yin
- National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China; (R.W.); (S.L.); (C.X.); (Y.W.); (W.Z.); (K.N.); (F.L.); (S.F.); (Q.Y.); (Y.H.); (S.X.); (G.L.)
| | - Ying He
- National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China; (R.W.); (S.L.); (C.X.); (Y.W.); (W.Z.); (K.N.); (F.L.); (S.F.); (Q.Y.); (Y.H.); (S.X.); (G.L.)
| | - Songtao Xu
- National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China; (R.W.); (S.L.); (C.X.); (Y.W.); (W.Z.); (K.N.); (F.L.); (S.F.); (Q.Y.); (Y.H.); (S.X.); (G.L.)
| | - Guodong Liang
- National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China; (R.W.); (S.L.); (C.X.); (Y.W.); (W.Z.); (K.N.); (F.L.); (S.F.); (Q.Y.); (Y.H.); (S.X.); (G.L.)
| | - Liquan Deng
- School of Public Health, Jilin University, Changchun 130021, China
| | - Qiang Wei
- National Pathogen Resource Center, Chinese Center for Disease Control and Prevention, Beijing 102206, China
| | - Huanyu Wang
- National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China; (R.W.); (S.L.); (C.X.); (Y.W.); (W.Z.); (K.N.); (F.L.); (S.F.); (Q.Y.); (Y.H.); (S.X.); (G.L.)
| |
Collapse
|
6
|
Ohira M, Yoshii K, Aso Y, Nakajima H, Yamashita T, Takahashi-Iwata I, Maeda N, Shindo K, Suenaga T, Matsuura T, Sugie K, Hamano T, Arai A, Furutani R, Suzuki Y, Kaneko C, Kobayashi Y, Campos-Alberto E, Harper LR, Edwards J, Bender C, Pilz A, Ito S, Angulo FJ, Erber W, Madhava H, Moïsi J, Jodar L, Mizusawa H, Takao M. First evidence of tick-borne encephalitis (TBE) outside of Hokkaido Island in Japan. Emerg Microbes Infect 2023; 12:2278898. [PMID: 37906509 PMCID: PMC10810618 DOI: 10.1080/22221751.2023.2278898] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/18/2023] [Accepted: 10/30/2023] [Indexed: 11/02/2023]
Abstract
Tick-borne encephalitis (TBE) is an infection of the central nervous system caused by the tick-borne encephalitis virus (TBEV). TBE is endemic in parts of Europe and Asia. TBEV is transmitted to humans primarily by Ixodes ticks. There have been 5 TBE cases identified in Japan, all on the northern island of Hokkaido. Rodents with TBEV antibodies and Ixodes ticks have been identified throughout Japan, indicating that TBEV infection might be undiagnosed in Japan. Residual serum and cerebrospinal fluid (CSF) collected in 2010-2021 from 520 patients ≥1 year-of-age previously hospitalized with encephalitis or meningitis of unknown etiology at 15 hospitals (including 13 hospitals outside of Hokkaido) were screened by ELISA for TBEV IgG and IgM antibodies; TBEV infection was confirmed by the gold standard neutralization test. Residual serum was available from 331 (63.6%) patients and CSF from 430 (82.6%) patients; both serum and CSF were available from 189 (36.3%). Two patients were TBE cases: a female aged 61 years hospitalized for 104 days in Oita (2000 km south of Hokkaido) and a male aged 24 years hospitalized for 11 days in Tokyo (1200 km south of Hokkaido). Retrospective testing also identified a previous TBEV infection in a female aged 45 years hospitalized for 12 days in Okayama (1700 km south of Hokkaido). TBEV infection should be considered as a potential cause of encephalitis or meningitis in Japan. TBE cases are likely undiagnosed in Japan, including outside of Hokkaido, due to limited clinical awareness and lack of availability of TBE diagnostic tests.
Collapse
Affiliation(s)
- Masayuki Ohira
- Department of Clinical Laboratory and Internal Medicine, National Center of Neurology and Psychiatry (NCNP), Tokyo, Japan
| | - Kentaro Yoshii
- National Research Center for the Control and Prevention of Infectious Diseases, Nagasaki University, Nagasaki City, Japan
| | - Yasuhiro Aso
- Department of Neurology, Oita Prefectural Hospital, Oita, Japan
| | - Hideto Nakajima
- Department of Neurology, Nihon University Itabashi Hospital, Tokyo, Japan
| | - Toru Yamashita
- Department of Neurology, Okayama University Hospital, Okayama, Japan
| | | | - Norihisa Maeda
- Department of Neurology, National Hospital Organization Beppu Medical Center, Oita, Japan
| | - Katsuro Shindo
- Department or Neurology, Kurashiki Central Hospital, Okayama, Japan
| | | | - Tohru Matsuura
- Division of Neurology, Jichi Medical University Hospital, Tochigi, Japan
| | - Kazuma Sugie
- Department of Neurology, Nara Medical University Hospital, Nara, Japan
| | - Tadanori Hamano
- Department of Neurology, University of Fukui Hospital, Fukui, Japan
| | - Akira Arai
- Aomori Prefectural Central Hospital, Aomori, Japan
| | - Rikiya Furutani
- Department of Neurology, National Hospital Organization Shinshu Ueda Medical Center, Nagano, Japan
| | - Yasuhiro Suzuki
- Department of Neurology, National Hospital Organization Asahikawa Medical Center, Hokkaido, Japan
| | - Chikako Kaneko
- Department of Neurology, Southern Tohoku General Hospital, Fukushima, Japan
| | | | | | - Lisa R. Harper
- Vaccines, Antivirals, and Evidence Generation, Pfizer Vaccines, Collegeville,PA, USA
| | - Juanita Edwards
- Vaccines, Antivirals, and Evidence Generation, Pfizer Vaccines, Collegeville,PA, USA
| | - Cody Bender
- Vaccines, Antivirals, and Evidence Generation, Pfizer Vaccines, Collegeville,PA, USA
| | - Andreas Pilz
- Vaccines, Antivirals, and Evidence Generation, Pfizer Vaccines, Vienna, Austria
| | - Shuhei Ito
- Vaccine Medical Affairs, Pfizer Japan Inc, Tokyo, Japan
| | - Frederick J. Angulo
- Vaccines, Antivirals, and Evidence Generation, Pfizer Vaccines, Collegeville,PA, USA
| | - Wilhelm Erber
- Vaccines, Antivirals, and Evidence Generation, Pfizer Vaccines, Vienna, Austria
| | - Harish Madhava
- Vaccines, Antivirals, and Evidence Generation, Pfizer Vaccines, London, UK
| | - Jennifer Moïsi
- Vaccines, Antivirals, and Evidence Generation, Pfizer Vaccines, Paris, France
| | - Luis Jodar
- Vaccines, Antivirals, and Evidence Generation, Pfizer Vaccines, Collegeville,PA, USA
| | - Hidehiro Mizusawa
- Department of Neurology, National Center of Neurology and Psychiatry (NCNP), Tokyo, Japan
| | - Masaki Takao
- Department of Clinical Laboratory and Internal Medicine, National Center of Neurology and Psychiatry (NCNP), Tokyo, Japan
| |
Collapse
|
7
|
Worku DA. Tick-Borne Encephalitis (TBE): From Tick to Pathology. J Clin Med 2023; 12:6859. [PMID: 37959323 PMCID: PMC10650904 DOI: 10.3390/jcm12216859] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/07/2023] [Revised: 10/19/2023] [Accepted: 10/25/2023] [Indexed: 11/15/2023] Open
Abstract
Tick-borne encephalitis (TBE) is a viral arthropod infection, endemic to large parts of Europe and Asia, and is characterised by neurological involvement, which can range from mild to severe, and in 33-60% of cases, it leads to a post-encephalitis syndrome and long-term morbidity. While TBE virus, now identified as Orthoflavivirus encephalitidis, was originally isolated in 1937, the pathogenesis of TBE is not fully appreciated with the mode of transmission (blood, tick, alimentary), viral strain, host immune response, and age, likely helping to shape the disease phenotype that we explore in this review. Importantly, the incidence of TBE is increasing, and due to global warming, its epidemiology is evolving, with new foci of transmission reported across Europe and in the UK. As such, a better understanding of the symptomatology, diagnostics, treatment, and prevention of TBE is required to inform healthcare professionals going forward, which this review addresses in detail. To this end, the need for robust national surveillance data and randomised control trial data regarding the use of various antivirals (e.g., Galidesivir and 7-deaza-2'-CMA), monoclonal antibodies, and glucocorticoids is required to improve the management and outcomes of TBE.
Collapse
Affiliation(s)
- Dominic Adam Worku
- Infectious Diseases, Morriston Hospital, Heol Maes Eglwys, Morriston, Swansea SA6 6NL, UK;
- Public Health Wales, 2 Capital Quarter, Cardiff CF10 4BZ, UK
| |
Collapse
|
8
|
Kwasnik M, Rola J, Rozek W. Tick-Borne Encephalitis-Review of the Current Status. J Clin Med 2023; 12:6603. [PMID: 37892741 PMCID: PMC10607749 DOI: 10.3390/jcm12206603] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/26/2023] [Revised: 09/01/2023] [Accepted: 10/16/2023] [Indexed: 10/29/2023] Open
Abstract
The tick-borne encephalitis virus (TBEV) is the arboviral etiological agent of tick-borne encephalitis (TBE), considered to be one of the most important tick-borne viral diseases in Europe and Asia. In recent years, an increase in the incidence of TBE as well as an increasing geographical range of the disease have been noted. Despite the COVID-19 pandemic and the imposition of restrictions that it necessitated, the incidence of TBE is rising in more than half of the European countries analyzed in recent studies. The virus is transmitted between ticks, animals, and humans. It seems that ticks and small mammals play a role in maintaining TBEV in nature. The disease can also affect dogs, horses, cattle, and small ruminants. Humans are incidental hosts, infected through the bite of an infected tick or by the alimentary route, through the consumption of unpasteurized milk or milk products from TBEV-infected animals. TBEV infections in humans may be asymptomatic, but the symptoms can range from mild flu-like to severe neurological. In Europe, cases of TBE are reported every year. While there is currently no effective treatment for TBE, immunization and protection against tick bites are critical in preventing this disease.
Collapse
Affiliation(s)
- Malgorzata Kwasnik
- Department of Virology, National Veterinary Research Institute, Al. Partyzantow 57, 24-100 Pulawy, Poland; (J.R.); (W.R.)
| | | | | |
Collapse
|